絞り込み

16645

広告

Erythropoiesis provides a BRD's eye view of BET protein function.

著者 Stonestrom AJ , Hsu SC , Werner MT , Blobel GA
Drug Discov Today Technol.2016 Mar ; 19():23-28.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (1view , 0users)

Full Text Sources

Pharmacologic inhibitors of the bromodomain and extra-terminal motif (BET) protein family are in clinical trials for the treatment of hematologic malignancies, yet the functions of individual BET proteins remain largely uncharacterized. We review the molecular roles of BETs in the context of erythropoiesis. Studies in this lineage have provided valuable insights into their mechanisms of action, and helped define the individual and overlapping functions of BET protein family members BRD2, BRD3, and BRD4. These studies have important ramifications for our understanding of the molecular and physiologic roles of BET proteins, and provide a framework for elucidating some of the beneficial and adverse effects of pharmacologic inhibitors.
PMID: 27769353 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード